Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images
Open Access
- 17 August 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 50 (1) , 67-79
Abstract
Purpose: This study aimed to develop and assess an automated segmentation framework based on deep learning for metastatic prostate cancer (mPCa) lesions in whole-body [68Ga]Ga-PSMA-11 PET/CT images for the purpose of extracting patient-level prognostic biomarkers. Methods: Three hundred thirty-seven [68Ga]Ga-PSMA-11 PET/CT images were retrieved from a cohort of biochemically recurrent PCa patients. A fully 3D convolutional neural network (CNN) is proposed which is based on the self-configuring nnU-Net framework, and was trained on a subset of these scans, with an independent test set reserved for model evaluation. Voxel-level segmentation results were assessed using the dice similarity coefficient (DSC), positive predictive value (PPV), and sensitivity. Sensitivity and PPV were calculated to assess lesion level detection; patient-level classification results were assessed by the accuracy, PPV, and sensitivity. Whole-body biomarkers total lesional volume (TLVauto) and total lesional uptake (TLUauto) were calculated from the automated segmentations, and Kaplan–Meier analysis was used to assess biomarker relationship with patient overall survival. Results: At the patient level, the accuracy, sensitivity, and PPV were all > 90%, with the best metric being the PPV (97.2%). PPV and sensitivity at the lesion level were 88.2% and 73.0%, respectively. DSC and PPV measured at the voxel level performed within measured inter-observer variability (DSC, median = 50.7% vs. second observer = 32%, p = 0.012; PPV, median = 64.9% vs. second observer = 25.7%, p < 0.005). Kaplan–Meier analysis of TLVauto and TLUauto showed they were significantly associated with patient overall survival (both p < 0.005). Conclusion: The fully automated assessment of whole-body [68Ga]Ga-PSMA-11 PET/CT images using deep learning shows significant promise, yielding accurate scan classification, voxel-level segmentations within inter-observer variability, and potentially clinically useful prognostic biomarkers associated with patient overall survival. Trial registration: This study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12615000608561) on 11 June 2015.Keywords
All Related Versions
Funding Information
- Royal Perth Hospital Imaging Research Committee (0010121)
This publication has 45 references indexed in Scilit:
- A survey on deep learning in medical image analysisMedical Image Analysis, 2017
- The Importance of Skip Connections in Biomedical Image Segmentation2016
- U-Net: Convolutional Networks for Biomedical Image Segmentation2015
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Reproducibility and Prognosis of Quantitative Features Extracted from CT ImagesTranslational Oncology, 2014
- Partial-Volume Effect in PET Tumor ImagingJournal of Nuclear Medicine, 2007
- Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancerJournal of Cellular Biochemistry, 2003
- Prognostic Value of 2-Deoxy-2-[F-18]Fluoro-D-Glucose Positron Emission Tomography Imaging for Patients with Prostate CancerMolecular Imaging and Biology, 2002
- Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planningRadiotherapy and Oncology, 1998
- Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissuesUrologic Oncology: Seminars and Original Investigations, 1995